Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial tenecteplase after intravenous tenecteplase for acute ischaemic stroke
ACTRN12621000696897Phase 2Terminated
- Sponsor
- Northern Sydney Local Health District
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tenecteplase in brain infarction, sponsored by Northern Sydney Local Health District. Primary endpoint: Proportion of patients with medium vessel recanalisation without symptomatic intracerebral haemorrhage. Started Aug 2021; status: terminated.
02
Drugs
tenecteplase
03
Conditions
brain infarction
Beyond the preview
Go deeper on ACTRN12621000696897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000696897.